Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.

Digestive diseases and sciences - 1 Jul 2018

Lian Lei, Huang Qunsheng, Zhang Longjuan, Qin Huabo, He Xiaosheng, He Xin, Ke Jia, Xie Minghao, Lan Ping

Abstract excerpt

BACKGROUND: Intestinal fibrosis is a major complication of CD and may result in stricture formation leading to intestinal obstruction. MSCs play multiple roles in active CD and fibrosis-associated diseases. AIMS: This study was designed to investigate the role of MSCs in CD-associated intestinal fibrosis. METHODS: Intestinal fibrosis was induced over 7 weeks of enema with increasing doses of TNBS and assessed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colon
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrosis

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Smad2 Protein

Share to Smad3 Protein

Share to Stem Cell Niche

Source

Identifiers

PMID: 29704139
DOI: 10.1007/s10620-018-5082-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.PMID 29704139Read ↗

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Semantic proximity Read ↗

Characterization of myofibroblasts isolated from the intestine of patients with inflammatory bowel diseaseSemantic proximity Read ↗

Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-β1-Induced Intestinal Fibrosis on CCD-18Co Cells.Semantic proximity Read ↗

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesenterySemantic proximity Read ↗

Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor ASemantic proximity Read ↗

Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathwaySemantic proximity Read ↗

Fibroblast Heterogeneity in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Stem Cell-Based Therapies for Inflammatory Bowel DiseaseSemantic proximity Read ↗

Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat modelSemantic proximity Read ↗

Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiotaSemantic proximity Read ↗

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.Semantic proximity Read ↗

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.